| Previous Close | 0.5500 |
| Open | 0.5700 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.5130 - 0.5700 |
| 52 Week Range | 0.5000 - 4.2300 |
| Volume | 10,362 |
| Avg. Volume | 88,403 |
| Market Cap | 59.117M |
| Beta (3Y Monthly) | 1.34 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TUCSON, AZ / ACCESSWIRE / July 10, 2019 / WEED, Inc. (BUDZ), a global Cannabis holding company focused on the development and application of cannabis-derived compounds for the treatment of human diseases, announced today that it was the winning bidder at the auction held to sell Greg DiPaolo’s Pro Am Golf, LLC property located in Westfield, New York. WEED, Inc. already owns water extraction rights related to the property.
WEED Inc. and its subsidiaries WEED Australia Ltd., WEED Hong Kong Limited along with WEED Israel Cannabis Ltd. were proud sponsors of the 2019 MardiGrass Cannabis law reform rally & gathering in Nimbin N.S.W. TUCSON, AZ / ACCESSWIRE / May 22, 2019 / WEED, Inc., (BUDZ) ("WEED") announced today that it, along with its 3 subsidiaries, were proud sponsors of Nimbin's Annual MardiGrass Festival held in Nimbin, Australia on May 3rd - May 5th 2019.
UPDATE: CEO is currently 'Down Under' at its subsidiaries, WEED Australia Ltd and The Cannabis Institute of Australia to discuss clinical 'CBD' trials to begin in Israel this year. TUCSON, AZ / ACCESSWIRE / March 20, 2019 / WEED, Inc., (BUDZ) (''WEED'') announced today that it has entered into an exclusive license and assignment agreement with Yissum, the technology transfer company of the Hebrew University of Jerusalem Ltd., Israel (''Yissum'').
TUCSON, AZ / ACCESSWIRE / December 11, 2018 / WEED, Inc. (BUDZ) (the ''Company'') or (''WEED'') announced that its first of many cultivar DNA sequencing tests have been perfected and finalized. ''During this time our team designed, tested, and refined standard operating procedures for efficient DNA isolation and sequencing of Cannabis genomes. Extensive bioinformatics analysis of repeatable and variable regions has been performed on newly-generated DNA sequencing data of 26 landrace cultivars and several publicly available genomes.'' stated CEO, Glenn E Martin.
TUCSON, AZ / ACCESSWIRE / October 18, 2018 / WEED, Inc. (BUDZ), a global Cannabis holding company focused on the development and application of cannabis–derived compounds for the treatment of human diseases, announced today that it has acquired the rights to two trademark registrations directed to the name of the company, WEED. The marks, which were acquired by WEED, Inc. from Copalix (PTY) Ltd., a private South African company, were assigned in the United States Patent Office and European Union Intellectual Property Office, respectively, on May 29 and August 14 of this year. The acquisitions include the purchase of a United States Trademark Registration (U.S. Trademark Registration No. 4,927,872) for the wordmark "WEED®" for pouches for carrying electronic cigarettes, mouth pieces for electronic cigarettes, and wicks for electronic cigarettes and a European Trademark Registration (European Community Trademark Registration No. 11953387) for the same wordmark "WEED®" for batteries and electronic accumulators, batteries for electronic cigarettes, chargers for electric cigarettes, battery chargers for electron cigarettes, USB chargers, car chargers, parts and fittings for the aforesaid goods and matches, pouches for carrying electronic cigarettes, mouth pieces for electronic cigarettes, rechargeable cigarette cases along with their parts and fittings.
WEED, Inc. Forms WEED Israel (Cannabis) Ltd, WEED Australia Ltd, and Cannabis Institute of Australia... TUCSON, AZ / ACCESSWIRE / September 10, 2018 / WEED, Inc. (OTC PINK: BUDZ) (the "Company" ...
TUCSON, AZ / ACCESSWIRE / August 13, 2018 / WEED, Inc. (OTC PINK: BUDZ) (the "Company" or "WEED"), a current alternative reporting public company focused on the development and application of cannabis-derived compounds for the treatment of human disease, announced that its Form S-1 resale registration statement relating to the resale of up to 8,982,015 shares of its common stock by certain selling shareholders (the "S-1") was declared effective by the Securities and Exchange Commission on August 8, 2018 at 4pm Eastern Time. The S-1 will, while effective, allow the selling shareholders listed in the S-1 to resell their shares of WEED, Inc.'s common stock, subject to the prospectus delivery requirements of the Securities Act of 1933, as amended, in connection with any such resale.